Name: Ketobemidone
Type: Opioid
AKA: Cliradon
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
III. Chemical Profile (IUPAC name)
|
IV. History
Ketobemidone, an opioid analgesic, was developed in the mid-20th century. It was used for its strong analgesic properties but has been largely replaced by newer medications due to safety and efficacy concerns.
|
V. Legal Information
Ketobemidone is an opioid analgesic with high potential for abuse. It is controlled under various drug regulations globally, including Schedule II in the United States. Its use is tightly regulated to prevent misuse and ensure safe medical application. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
Ketobemidone is a synthetic opioid used for pain relief. It functions as a downer, leading to sedation and respiratory depression. While effective for pain management, long-term use can cause addiction and tolerance. Overdose risks involve severe respiratory depression and potential death. Safe use involves strict medical supervision. Recent studies focus on its comparative efficacy and safety relative to other opioids. |
VII. Psychological Effects
Ketobemidone is an opioid with strong analgesic effects. Short-term use can lead to mood elevation and sedation, while long-term use may result in addiction, cognitive impairments, and mood disorders. Research emphasizes its impact on opioid receptors and psychological risks.
|
VIII. Culture
Ketobemidone is an opioid analgesic used for pain management. Its cultural significance lies in its role in treating pain and its potential for abuse. Media coverage often addresses its efficacy and the risks associated with opioid use. Ketobemidone is used medicinally and contributes to discussions about opioid use and addiction treatment.
|